Change in Weight from Baseline with Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Servizos
Servizos
Data de publicación
2014Título da revista
Arthritis and Rheumatology
Tipo de contido
Publicación de congreso
